Patient from Australia discusses improvement in post-stroke pain, fatigue, cognition, walking, and speech after PSE treatment by Dr. Tobinick, 4 years after stroke. Filmed January 16 & January 23, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Patient from Australia exhibits improvement in spasticity, sensation, walking, swallowing, and feet swelling/discoloration after PSE treatment by Dr. Tobinick, 13 months after stroke. Filmed January 2 & January 9, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Rapid improvement in post-stroke pain, walking, spasticity, and swallowing after PSE treatment by Dr. Tobinick, over 3 years after stroke. Filmed December 12, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvement in ataxia, speech, and walking after PSE treatment by Dr. Tobinick, 3.5 years after stroke. Filmed November 18, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvement in walking, speech, sensation, swallowing, balance, and hand function after PSE treatment by Dr. Tobinick, 1 year after stroke. Filmed October 24 & October 31, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0